amlodipin/valsartan/hct beta 10 mg/160 mg/25 mg filmtabletten
betapharm arzneimittel gmbh (3364323) - amlodipinbesilat; valsartan; hydrochlorothiazid - filmtablette - teil 1 - filmtablette; amlodipinbesilat (24866) 13,87 milligramm; valsartan (26826) 160 milligramm; hydrochlorothiazid (00512) 25 milligramm
amlodipin/valsartan/hct beta 10 mg/160 mg/12,5 mg filmtabletten
betapharm arzneimittel gmbh (3364323) - amlodipinbesilat; valsartan; hydrochlorothiazid - filmtablette - teil 1 - filmtablette; amlodipinbesilat (24866) 13,87 milligramm; valsartan (26826) 160 milligramm; hydrochlorothiazid (00512) 12,5 milligramm
amlodipin/valsartan/hct beta 5 mg/160 mg/25 mg filmtabletten
betapharm arzneimittel gmbh (3364323) - amlodipinbesilat; valsartan; hydrochlorothiazid - filmtablette - teil 1 - filmtablette; amlodipinbesilat (24866) 6,935 milligramm; valsartan (26826) 160 milligramm; hydrochlorothiazid (00512) 25 milligramm
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - magen-neoplasmen - antineoplastische mittel - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
tyenne
fresenius kabi deutschland gmbh - tocilizumab - arthritis, rheumatoid; cytokine release syndrome; arthritis, juvenile rheumatoid; covid-19 virus infection; giant cell arteritis - immunsuppressiva - tyenne, in combination with methotrexate (mtx), is indicated for- the treatment of severe, active and progressive rheumatoid arthritis (ra) in adults not previously treated with mtx. - the treatment of moderate to severe active ra in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease-modifying anti-rheumatic drugs (dmards) or tumour necrosis factor (tnf) antagonists. in these patients, tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tocilizumab has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function when given in combination with methotrexate. tyenne is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. tyenne is indicated for the treatment of active systemic juvenile idiopathic arthritis (sjia) in patients 1 year of age and older, who have responded inadequately to previous therapy with nsaids and systemic corticosteroids. tyenne can be given as monotherapy (in case of intolerance to mtx or where treatment with mtx is inappropriate) or in combination with mtx. tyenne in combination with methotrexate (mtx) is indicated for the treatment of juvenile idiopathic polyarthritis (pjia; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with mtx. tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tyenne is indicated for the treatment of chimeric antigen receptor (car) t cell-induced severe or life-threatening cytokine release syndrome (crs) in adults and paediatric patients 2 years of age and older. tyenne is indicated for the treatment of giant cell arteritis (gca) in adult patients.
anastrozol abz 1 mg filmtabletten
abz-pharma gmbh - geschäftsanschrift - (4238075) - anastrozol - filmtablette - teil 1 - filmtablette; anastrozol (27057) 1 milligramm
endoxan
baxter oncology gmbh (8044474) - cyclophosphamid 1 h<2>o - überzogene tablette - teil 1 - überzogene tablette; cyclophosphamid 1 h<2>o (12932) 53,5 milligramm
lorzaar plus 50/12,5 mg filmtabletten
organon healthcare gmbh (1007295) - hydrochlorothiazid; losartan-kalium - filmtablette - teil 1 - filmtablette; hydrochlorothiazid (00512) 12,5 milligramm; losartan-kalium (26551) 50 milligramm
lorzaar plus forte 100/12,5 mg filmtabletten
organon healthcare gmbh (1007295) - losartan-kalium; hydrochlorothiazid - filmtablette - teil 1 - filmtablette; losartan-kalium (26551) 100 milligramm; hydrochlorothiazid (00512) 12,5 milligramm
telmicard 20 mg-tabletten
g.l. pharma gmbh - telmisartan -